THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY

被引:1064
|
作者
DYCK, PJ
KRATZ, KM
KARNES, JL
LITCHY, WJ
KLEIN, R
PACH, JM
WILSON, DM
OBRIEN, PC
MELTON, LJ
机构
[1] MAYO CLIN & MAYO FDN, DEPT INTERNAL MED, DIV NEPHROL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, DEPT APPL MECH, ROCHESTER, MN 55905 USA
[3] MAYO CLIN & MAYO FDN, BIOSTAT SECT, ROCHESTER, MN 55905 USA
[4] MAYO CLIN & MAYO FDN, CLIN EPIDEMIOL SECT, ROCHESTER, MN 55905 USA
[5] UNIV WASHINGTON, DEPT APPL MECH, SEATTLE, WA 98195 USA
[6] UNIV WASHINGTON, CTR ANIM RES, SEATTLE, WA 98195 USA
关键词
D O I
10.1212/WNL.43.4.817
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The magnitude of the health problem from diabetic neuropathies remains inadequately estimated due to the lack of prospective population-based studies employing standardized and validated assessments of the type and stage of neuropathy as compared with background frequency. All Rochester, Minnesota, residents with diabetes mellitus on January 1, 1986, were invited to participate in a cross-sectional and longitudinal study of diabetic neuropathies (and also of other microvascular and macrovascular complications). Of 64,573 inhabitants on January 1, 1986 in Rochester, 870 (1.3%) had clinically recognized diabetes mellitus (National Diabetes Data Group criteria), of whom 380 were enrolled in the Rochester Diabetic Neuropathy Study. Of these, 102 (26.8%) had insulin-dependent diabetes mellitus (IDDM), and 278 (73.2%) had non-insulin-dependent diabetes mellitus (NIDDM). Approximately 10% of diabetic patients had neurologic deficits attributable to nondiabetic causes. Sixty-six percent of IDDM patients had some form of neuropathy; the frequencies of individual types were as follows: polyneuropathy, 54%; carpal tunnel syndrome, asymptomatic, 22%, and symptomatic, 11%; visceral autonomic neuropathy, 7%; and other varieties, 3%. Among NIDDM patients, 59% had various neuropathies; the individual percentages were 45%, 29%, 6%, 5%, and 3%. Symptomatic degrees of polyneuropathy occurred in only 15% of IDDM and 13% of NIDDM patients. The more severe stage of polyneuropathy, to the point that patients were unable to walk on their heels and also had distal sensory and autonomic deficits (stage 2b) occurred even less frequently-6% of IDDM and 1% of NIDDM patients. Overall, two thirds of diabetic patients have objective evidence for some variety of neuropathy, but only about 20% have symptoms, and only 6% of IDDM and only 1% of NIDDM patients have sufficiently severe polyneuropathy to be graded stage 2b, and none were graded stage 3. Approximately one quarter of patients had subclinical carpal tunnel syndrome, but only 7.7% had symptomatic carpal tunnel syndrome. Thus, diabetic peripheral neuropathy is frequent but less severe than generally thought. As generally believed, however, neuropathy, retinopathy, and nephropathy are significantly associated.
引用
收藏
页码:817 / 824
页数:8
相关论文
共 50 条
  • [21] Clinically diagnosed diabetic neuropathy: Frequency, types and severity
    Ugoya, Solomon O.
    Echejoh, Godwins O.
    Ugoya, Tokunbo A.
    Agaba, Emmanuel I.
    Puepet, Fabian H.
    Ogunniyi, Adesola
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (11) : 1763 - 1766
  • [22] AN ANALYTICAL STUDY TO EVALUATE SEVERITY OF DIABETIC RETINOPATHY AND INCIDENCE OF NEUROPATHY, NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Senthil, Karupputhevar
    Saravanasankar, Pandiaraj
    Bagavathshalini, Mohan
    Hemmanthraj, Madhavan
    Sruthi, Rethy Sreekumar
    Cinushamasilthilakraj, Francis Xavier Rajan
    Shaminabegum, Abdullah Haroon
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (93): : 6875 - 6878
  • [23] PREVALENCE OF AUTONOMIC NEUROPATHY IN A DIABETIC CLINIC POPULATION
    HAYTER, RC
    WILLIAMS, JG
    MORRIS, AI
    MACAULAY, MB
    COHEN, SB
    DIABETOLOGIA, 1981, 21 (05) : 508 - 508
  • [24] Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy
    Candrilli, Sean D.
    Davis, Keith L.
    Kan, Hong J.
    Lucero, Melanie A.
    Rousculp, Matthew D.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (05) : 306 - 314
  • [25] Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in China
    Wang, Weimin
    Ji, Qiuhe
    Ran, Xinwu
    Li, Chenxi
    Kuang, Hongyu
    Yu, Xuefeng
    Fang, Hui
    Yang, Jing
    Liu, Jing
    Xue, Yaoming
    Feng, Bo
    Lei, Minxiang
    Zhu, Dalong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (08)
  • [26] Octreotide improves diabetic nephropathy, neuropathy and glycemic control, but not retinopathy.
    Grant, MB
    Mames, RN
    Caballero, S
    Fitzgerald, C
    DIABETES, 1996, 45 : 52 - 52
  • [27] DIABETIC-RETINOPATHY, NEPHROPATHY, AND NEUROPATHY WITH NORMAL GLUCOSE-TOLERANCE
    KABADI, UM
    DIABETES CARE, 1986, 9 (02) : 211 - 211
  • [28] Population-based study of diabetic retinopathy in Wolfsburg
    Hesse, L
    Grüsser, M
    Hoffstadt, K
    Jörgens, V
    Hartmann, P
    Kroll, P
    OPHTHALMOLOGE, 2001, 98 (11): : 1065 - 1068
  • [29] Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study
    Adam, Safwaan
    Azmi, Shazli
    Ho, Jan H.
    Liu, Yifen
    Ferdousi, Maryam
    Siahmansur, Tarza
    Kalteniece, Alise
    Marshall, Andrew
    Dhage, Shaishav S.
    Iqbal, Zohaib
    D'Souza, Yvonne
    Natha, Salim
    Kalra, Philip A.
    Donn, Rachelle
    Ammori, Basil J.
    Syed, Akheel A.
    Durrington, Paul N.
    Malik, Rayaz A.
    Soran, Handrean
    OBESITY SURGERY, 2021, 31 (02) : 554 - 563
  • [30] Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study
    Safwaan Adam
    Shazli Azmi
    Jan H. Ho
    Yifen Liu
    Maryam Ferdousi
    Tarza Siahmansur
    Alise Kalteniece
    Andrew Marshall
    Shaishav S. Dhage
    Zohaib Iqbal
    Yvonne D’Souza
    Salim Natha
    Philip A. Kalra
    Rachelle Donn
    Basil J. Ammori
    Akheel A. Syed
    Paul N. Durrington
    Rayaz A. Malik
    Handrean Soran
    Obesity Surgery, 2021, 31 : 554 - 563